SUNSHINE BIOPHARMA INC's ticker is and the CUSIP is 867781403. A total of 12 filers reported holding SUNSHINE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,870 | -35.5% | 6,042 | 0.0% | 0.00% | – |
| Q2 2023 | $2,900 | -31.4% | 6,042 | 0.0% | 0.00% | – |
| Q1 2023 | $4,230 | +9.4% | 6,042 | 0.0% | 0.00% | – |
| Q4 2022 | $3,867 | +286.7% | 6,042 | +479.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,042 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 1,042 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | – | 1,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,100 | $221,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 17,019 | $13,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,179 | $15,000 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 1,042 | $1,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 30,000 | $33,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,849 | $11,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 16,846 | $13,000 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 37,386 | $29,000 | 0.00% |